Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yang-Yi Bao"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kai-Xun Hu, Jian-Hui Qiao, Hui-Sheng Ai, Bo Cai, Hong-Li Zuo, Anthony D. Sung, Lin-Hua Yang, Xuliang Shen, Wei-Wei Liu, Yang-Yi Bao, Wan-Jun Sun, Elizabeth F. Krakow, Depei Wu, Rafael Fores, Qi-Yun Sun, Xinrong Zhan, Li Liu, Ann Mohrbacher, David A. Rizzieri, Jian-Yong Li, Si-Xuan Qian, Nelson J. Chao, Juan Wang, Zhiqing Liu, Ya-Jing Huang, Zheng Dong, Bo Yao, Hong-Xia Zhao, Tie-Qiang Liu, Jun-Xiao Qiao, Chang-Lin Yu, Rafael F. Duarte, Min Zhou, Mei Guo
Importance The outcome of older patients with acute myeloid leukemia (AML) remains unsatisfactory. Recent studies have shown that HLA-mismatched microtransplant could improve outcomes in such patients. Objective To evaluate outcomes in different age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e27d342a97ee759f71763cbcc847569
https://europepmc.org/articles/PMC5833633/
https://europepmc.org/articles/PMC5833633/
Autor:
Mei Guo, Chao, Nelson J., Jian-Yong Li, Rizzieri, David A., Qi-Yun Sun, Mohrbacher, Ann, Krakow, Elizabeth F., Wan-Jun Sun, Xu-Liang Shen, Xin-Rong Zhan, De-Pei Wu, Li Liu, Juan Wang, Min Zhou, Lin-Hua Yang, Yang-Yi Bao, Zheng Dong, Bo Cai, Kai-Xun Hu, Chang-Lin Yu
Publikováno v:
JAMA Oncology; Jan2018, Vol. 4 Issue 1, p54-62, 9p, 4 Graphs
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 19(2)
Mesenchymal stem cells (MSC) are the ideal adult stem cells in cell/gene therapy and tissue engineering for their features of easily-handling, highly proliferative capacity in vitro, low immunogenicity and immunomodulatory ability. MSC, as a kind of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45ebe754da01d6da00ae614a5ec1790a
https://pubmed.ncbi.nlm.nih.gov/21518526
https://pubmed.ncbi.nlm.nih.gov/21518526
Autor:
Mei Guo, Hong-Li Zuo, Qi-Yun Sun, Xuzhang Lu, Hui-Sheng Ai, Lin-Hua Yang, Hong-Xia Zhao, Jian-Hui Qiao, Jianyong Li, Bo Cai, Xinrong Zhan, Li Liu, Zheng Dong, Juan Wang, Tie-Qiang Liu, Jun-Xiao Qiao, Chang-Lin Yu, Ya-Jing Huang, Depei Wu, Yang-Yi Bao, Wan-Jun Sun, Kai-Xun Hu, Bo Yao, Xuliang Shen, Zhiqing Liu
Publikováno v:
Blood. 126:455-455
The acute myeloid leukemia in elderly patients (EAML) is always associated with low complete remission (CR) rate and a poor survival due to prolonged pancytopenia and resistance of leukemic blasts to chemotherapy. The standard or high dose induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb0519acde6ec88565df3fb30274a77e
https://doi.org/10.1182/blood.v126.23.455.455
https://doi.org/10.1182/blood.v126.23.455.455